Table I Index
Table of Contents

Table I - 2
Allen
Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana

Primary Site

Total

Males Females
Number Rate Number Rate Number Rate
All sites 1,126 332.2 529 366.6 597 310.0
Oral cavity and pharynx 21 6.4 16 10.7** 5 3.1**
Lip * # * # * #
Tongue * # * # * #
Major salivary glands 5 1.5** * # * #
Floor of mouth * # * # * #
Gum and other mouth * # * # * #
Nasopharynx * # * # * #
Tonsil * # * # * #
Oropharynx * # * # * #
Hypopharynx * # * # * #
Pharynx and other oral cavity * # * # * #
Digestive system 223 63.9 114 78.8 109 52.3
Esophagus 16 4.5** 12 8.0** * #
Stomach 8 2.3** 5 3.7** * #
Small intestine 6 1.7** * # * #
Colon excluding rectum 114 31.8 53 36.7 61 27.9
Rectum and rectosigmoid 44 12.8 24 16.8 20 9.8
Anus, anal canal, and anorectum * # * # * #
Liver and intrahepatic bile duct * # * # * #
Gallbladder * # * # * #
Other biliary * # * # * #
Pancreas 22 6.7 12 8.0** 10 5.7**
Retroperitoneum * # * # * #
Peritoneum * # * # * #
Other digestive organs * # * # * #
Respiratory system 181 55.6 111 78.8 70 37.3
Nasal cavity, ear, and sinuses * # * # * #
Larynx 16 5.1** 15 10.6** * #
Lung and bronchus 160 48.8 92 65.2 68 36.0
Trachea, pleura, and other respiratory organs * # * # * #
Bones and joints * # * # * #
Soft tissue (including heart) 8 2.5** 5 3.0** * #
Skin (excluding basal and squamous) 22 6.2 11 7.1** 11 5.9**
Melanoma of the skin 16 4.5** 7 4.6** 9 4.7**
Other non-epithelial skin cancers 6 1.8** * # * #
Breast 192 54.7 * # 190 98.1
Female genital system 104 31.0 -- -- 104 57.5
Cervix uteri 22 6.0 -- -- 22 11.5
Corpus uteri 46 14.0 -- -- 46 25.7
Uterus, NOS * # -- -- * #
Ovary 29 9.0 -- -- 29 16.9
Vagina * # -- -- * #
Vulva 5 1.5** -- -- 5 2.5**
Other female genital organs * # -- -- * #
Male genital system 126 38.4 126 88.6 -- --
Prostate gland 122 37.5 122 86.7 -- --
Testis * # * # -- --
Penis * # * # -- --
Other male genital organs * # * # -- --
Urinary system 99 28.0 68 45.4 31 14.5
Urinary bladder 51 14.4 39 26.7 12 5.5**
Kidney and renal pelvis 41 11.9 25 16.1 16 8.2**
Ureter * # * # * #
Other urinary organs * # * # * #
Eye and orbit * # * # * #
Brain and other nervous system 22 6.7 13 9.1** 9 4.5**
Brain 22 6.7 13 9.1** 9 4.5**
Other nervous system * # * # * #
Endocrine system 19 5.3** 5 3.1** 14 7.5**
Thyroid gland 18 5.0** * # 14 7.5**
Other endocrine (including thymus) * # * # * #
Lymphoma 50 15.6 25 17.5 25 13.5
Hodgkin’s disease 8 2.7** * # * #
Non-Hodgkin’s lymphoma 42 12.9 21 14.4 21 11.3
Multiple myeloma 8 2.4** * # * #
Leukemia 20 6.5 14 10.3** 6 2.9**
Acute lymphocytic * # * # * #
Chronic lymphocytic * # * # * #
Acute myeloid 10 3.2** 6 4.7** * #
Chronic myeloid * # * # * #
Other leukemias * # * # * #
Other, ill-defined and unknown sites 27 7.7 12 7.8** 15 8.0**

1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin.
* Fewer than 5 cases, number suppressed to protect confidentiality.
** Rates based on fewer than twenty cases are unstable.
# Rate cannot be calculated.
_______________________________________________________________

Source:  Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001

Table I Index
Table of Contents